跳至主要内容
临床试验/NCT03618225
NCT03618225已完成4 期

Duloxetine Role in Reducing Opioid Consumption After Thoracotomy

Assiut University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年8月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Total dose of morphine needed to treat postoperative pain

研究概览

简要总结

A total of 60 patients scheduled for thoracotomy with the aim of excision of pleural or lung cancer, will be randomized by the use of a computer-generated table of random numbers to receive duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure or a placebo pill following the same time schedule.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

duloxetine group

Active Comparator

duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure.

干预措施: Oral Duloxetine 60mg (Drug)

placebo pill group

Placebo Comparator

placebo pill orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure.

干预措施: placebo pill (Drug)

结局指标

主要结局

Total dose of morphine needed to treat postoperative pain

时间窗: 48 hours

Total dose of morphine needed to treat postoperative pain over 48 hours of study period

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed H Othman

Assisstant professor of Anesthesia ICU and pain Relief

Assiut University

研究点 (1)

Loading locations...

相似试验

Duloxetine Role in Reducing Opioid Consumption After... | 临床试验